BioMarin (BMRN) announced positive new data from studies of Voxzogo in children with achondroplasia and in ongoing clinical trials ...

Voxzogo (vox-ZOE-goe) is an injection medicine that was approved in 2021 for the treatment of achondroplasia. It is the first FDA-approved treatment for achondroplasia in children with open growth ...

VOXZOGO for achondroplasia experienced 56% year-over-year growth, driven by global expansion and increased penetration in younger pediatric patients. Management also revealed plans to expand ...

Longer term, we forecast high-single-digit revenue growth for these therapies. Achondroplasia treatment Voxzogo has continued to achieve strong patient uptake globally, and it recorded revenue of ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

Leadership across skeletal conditions is anchored to global expansion of VOXZOGO for achondroplasia which grew 56% year-over-year with plans to expand into hypochondroplasia 2027, as well as four ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

Strong sales of Voxzogo drove this upside. The top line beat the Zacks Consensus Estimate of $711.9 million. Product revenues totaled $735.6 million, which rose 16% year over year on higher ...

Total Revenues increased 16% year over year, driven by Voxzogo contributions from new patient starts in all regions. In the quarter, revenues from BioMarin's Enzyme Therapies increased 9% ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...